Intralenticular Ozurdex® - One Year Later

Reported here is a case of intralenticular sustained-release dexamethasone implant (Ozurdex®, Allergan, Irvine, CA, USA) present for 1 year with effective treatment of refractory diabetic macular edema without rapid cataract formation. The crystalline lens remained stable for 12 months on exam despi...

Descripción completa

Detalles Bibliográficos
Autores principales: Regan, Kathleen A., Blake, Charles R., Lukowski, Zachary L., Iyer, Siva S.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836234/
https://www.ncbi.nlm.nih.gov/pubmed/29515431
http://dx.doi.org/10.1159/000485318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836234/
https://www.ncbi.nlm.nih.gov/pubmed/29515431
http://dx.doi.org/10.1159/000485318

Ejemplares similares